Home » Blog Index » News » FDA is expected to authorize the Pfizer’s COVID-19 vaccine for young adults age 12 and older

FDA is expected to authorize the Pfizer’s COVID-19 vaccine for young adults age 12 and older

Posted on May 5, 2021 at 5:00 am by John Lynch
FDA is expected to authorize the Pfizer’s COVID-19 vaccine for young adults age 12 and older

FILE - In this Monday, Nov. 23, 2015, file photo, the Pfizer logo is displayed at world headquarters in New York. On Monday, Nov. 9, 2020, Pfizer said an early peek at its vaccine data suggests the shots may be 90% effective at preventing COVID-19. (AP Photo/Mark Lennihan, File)

The Food and Drug Administration is expected to authorize the Pfizer’s COVID-19 vaccine for young adults age 12 and older by next week,

The announcement is set to come a month after the company found that its shot, which is already authorized for those age 16 and older, also provided protection for the younger group.

Pfizer in late March released preliminary results from a vaccine study that showed the vaccine was effective for 12 to 15 year old.

. (AP Photo/Mark Lennihan, File)

Powered By SoCast